---
document_datetime: 2025-12-02 06:35:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/nonafact.html
document_name: nonafact.html
version: success
processing_time: 0.1030895
conversion_datetime: 2025-12-28 09:10:17.970377
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Nonafact

[RSS](/en/individual-human-medicine.xml/65744)

##### Withdrawn

This medicine's authorisation has been withdrawn

human coagulation factor IX Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 May 2019, the European Commission withdrew the marketing authorisation for Nonafact (human coagulation factor IX) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Sanquin Plasma Products B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Nonafact was granted marketing authorisation in the EU on 3 July 2001 for treatment of haemophilia B. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2006.

The European Public Assessment Report (EPAR) for Nonafact is updated to indicate that the marketing authorisation is no longer valid.

Nonafact : EPAR - Summary for the public

English (EN) (1.17 MB - PDF)

**First published:** 11/09/2006

**Last updated:** 18/02/2020

[View](/en/documents/overview/nonafact-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-200)

български (BG) (724.48 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/bg/documents/overview/nonafact-epar-summary-public_bg.pdf)

español (ES) (631.1 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/es/documents/overview/nonafact-epar-summary-public_es.pdf)

čeština (CS) (1.28 MB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/cs/documents/overview/nonafact-epar-summary-public_cs.pdf)

dansk (DA) (1.17 MB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/da/documents/overview/nonafact-epar-summary-public_da.pdf)

Deutsch (DE) (1.17 MB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/de/documents/overview/nonafact-epar-summary-public_de.pdf)

eesti keel (ET) (630.08 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/et/documents/overview/nonafact-epar-summary-public_et.pdf)

ελληνικά (EL) (1.32 MB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/el/documents/overview/nonafact-epar-summary-public_el.pdf)

français (FR) (632 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/fr/documents/overview/nonafact-epar-summary-public_fr.pdf)

hrvatski (HR) (651.68 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/hr/documents/overview/nonafact-epar-summary-public_hr.pdf)

italiano (IT) (630.99 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/it/documents/overview/nonafact-epar-summary-public_it.pdf)

latviešu valoda (LV) (1.26 MB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/lv/documents/overview/nonafact-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (654.33 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/lt/documents/overview/nonafact-epar-summary-public_lt.pdf)

magyar (HU) (697.06 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/hu/documents/overview/nonafact-epar-summary-public_hu.pdf)

Malti (MT) (705.64 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/mt/documents/overview/nonafact-epar-summary-public_mt.pdf)

Nederlands (NL) (632.18 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/nl/documents/overview/nonafact-epar-summary-public_nl.pdf)

polski (PL) (677.25 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/pl/documents/overview/nonafact-epar-summary-public_pl.pdf)

português (PT) (630.8 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/pt/documents/overview/nonafact-epar-summary-public_pt.pdf)

română (RO) (652.2 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/ro/documents/overview/nonafact-epar-summary-public_ro.pdf)

slovenčina (SK) (702.68 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/sk/documents/overview/nonafact-epar-summary-public_sk.pdf)

slovenščina (SL) (696.3 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/sl/documents/overview/nonafact-epar-summary-public_sl.pdf)

Suomi (FI) (630.29 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/fi/documents/overview/nonafact-epar-summary-public_fi.pdf)

svenska (SV) (631.66 KB - PDF)

**First published:**

11/09/2006

**Last updated:**

18/02/2020

[View](/sv/documents/overview/nonafact-epar-summary-public_sv.pdf)

## Product information

Nonafact : EPAR - Product Information

English (EN) (723.28 KB - PDF)

**First published:** 18/12/2007

**Last updated:** 18/02/2020

[View](/en/documents/product-information/nonafact-epar-product-information_en.pdf)

[Other languages (22)](#file-language-dropdown-549)

български (BG) (1.46 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/bg/documents/product-information/nonafact-epar-product-information_bg.pdf)

español (ES) (701.19 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/es/documents/product-information/nonafact-epar-product-information_es.pdf)

čeština (CS) (2.16 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/cs/documents/product-information/nonafact-epar-product-information_cs.pdf)

dansk (DA) (1.28 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/da/documents/product-information/nonafact-epar-product-information_da.pdf)

Deutsch (DE) (1.29 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/de/documents/product-information/nonafact-epar-product-information_de.pdf)

eesti keel (ET) (756.74 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/et/documents/product-information/nonafact-epar-product-information_et.pdf)

ελληνικά (EL) (2.52 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/el/documents/product-information/nonafact-epar-product-information_el.pdf)

français (FR) (722.23 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/fr/documents/product-information/nonafact-epar-product-information_fr.pdf)

hrvatski (HR) (917.01 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/hr/documents/product-information/nonafact-epar-product-information_hr.pdf)

italiano (IT) (701 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/it/documents/product-information/nonafact-epar-product-information_it.pdf)

latviešu valoda (LV) (1.93 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/lv/documents/product-information/nonafact-epar-product-information_lv.pdf)

lietuvių kalba (LT) (881.32 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/lt/documents/product-information/nonafact-epar-product-information_lt.pdf)

magyar (HU) (1.2 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/hu/documents/product-information/nonafact-epar-product-information_hu.pdf)

Malti (MT) (1.22 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/mt/documents/product-information/nonafact-epar-product-information_mt.pdf)

Nederlands (NL) (740.48 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/nl/documents/product-information/nonafact-epar-product-information_nl.pdf)

polski (PL) (1.26 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/pl/documents/product-information/nonafact-epar-product-information_pl.pdf)

português (PT) (723.26 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/pt/documents/product-information/nonafact-epar-product-information_pt.pdf)

română (RO) (883.77 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/ro/documents/product-information/nonafact-epar-product-information_ro.pdf)

slovenčina (SK) (1.23 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/sk/documents/product-information/nonafact-epar-product-information_sk.pdf)

slovenščina (SL) (1.19 MB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/sl/documents/product-information/nonafact-epar-product-information_sl.pdf)

Suomi (FI) (705.99 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/fi/documents/product-information/nonafact-epar-product-information_fi.pdf)

svenska (SV) (718.96 KB - PDF)

**First published:**

18/12/2007

**Last updated:**

18/02/2020

[View](/sv/documents/product-information/nonafact-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0062 24/11/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Nonafact : EPAR - All Authorised presentations

English (EN) (661.7 KB - PDF)

**First published:** 15/11/2005

**Last updated:** 18/02/2020

[View](/en/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-273)

български (BG) (678.58 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/bg/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_bg.pdf)

español (ES) (658.5 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/es/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_es.pdf)

čeština (CS) (665.25 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/cs/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (663.15 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/da/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (665.66 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/de/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (625.82 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/et/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (692.11 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/el/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_el.pdf)

français (FR) (657.87 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/fr/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (657.42 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/it/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (1.2 MB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/lv/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (644.52 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/lt/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (643.21 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/hu/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (662.72 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/mt/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (660.32 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/nl/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_nl.pdf)

polski (PL) (665.83 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/pl/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_pl.pdf)

português (PT) (658.44 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/pt/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_pt.pdf)

română (RO) (647.42 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/ro/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (663.13 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/sk/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (649.75 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/sl/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (658.13 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/fi/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (661 KB - PDF)

**First published:**

15/11/2005

**Last updated:**

18/02/2020

[View](/sv/documents/all-authorised-presentations/nonafact-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Nonafact Active substance human coagulation factor IX International non-proprietary name (INN) or common name human coagulation factor IX Therapeutic area (MeSH) Hemophilia B Anatomical therapeutic chemical (ATC) code B02BD04

### Pharmacotherapeutic group

Antihemorrhagics

### Therapeutic indication

Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).

## Authorisation details

EMA product number EMEA/H/C/000348 Marketing authorisation holder

Sanquin Plasma Products B.V.

Plesmanlaan 125

Marketing authorisation issued 03/07/2001 Revision 9

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Nonafact : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1.24 MB - PDF)

**First published:** 18/12/2007

**Last updated:** 18/02/2020

[View](/en/documents/procedural-steps-after/nonafact-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Nonafact : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (888.66 KB - PDF)

**First published:** 15/11/2005

**Last updated:** 29/04/2020

[View](/en/documents/steps-after-cutoff/nonafact-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Nonafact : EPAR - Procedural steps taken before authorisation

English (EN) (961.53 KB - PDF)

**First published:** 15/11/2005

**Last updated:** 29/04/2020

[View](/en/documents/procedural-steps/nonafact-epar-procedural-steps-taken-authorisation_en.pdf)

Nonafact : EPAR - Scientific Discussion

English (EN) (831.94 KB - PDF)

**First published:** 15/11/2005

**Last updated:** 18/02/2020

[View](/en/documents/scientific-discussion/nonafact-epar-scientific-discussion_en.pdf)

**This page was last updated on** 18/02/2020

## Share this page

[Back to top](#main-content)